Coronavirus: Commission signs a joint procurement contract with Gilead for the supply of Remdesivir

European Commission Press release Brussels, 08 Oct 2020 The Commission has signed a joint procurement framework contract with the pharmaceutical company Gilead for the supply of up to 500,000 treatment courses of Veklury, the brand name for Remdesivir, and the opportunity to increase supply beyond the 500,000 treatment courses.

Other news